We are participating in national and international clinical trials with newly developed drugs. Therefore we can offer the most recent therapies at a very early stage in the treatment of patients with psoriasis.
In studies with internal drug substances, generally patients with moderate to severe forms of psoriasis can be included in most clinical trials. For participation approximately 10% or more of the body surface area should be affected by psoriasis (1 palm from the fingertips to the wrist is equivalent to 1% of the body surface area). It has to be persisting for at least six months and should be diagnosed by a dermatologist.
It is our pleasure to inform you about a possible participation in clinical trials at our center. Please contact us during our consulting hours while visiting or contact us directly.
Clinical trials for adult patients with moderate to severe forms of psoriasis vulgaris: there are currently several studies with different internal preparations available. If you are interested in participating we are happy to provide you with more information in a personal conversation.